Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Thyroid hormone deficiency can have important repercussions. Treatment with thyroid
hormone in replacement doses is essential in patients with hypothyroidism. In this review …

The earthquake and tsunami in Japan on 11 March 2011 led to releases of radioactive
material into the environment from the Tokyo Electric Power Company's Fukushima Daiichi …

This document provides the new EANM guideline on radioiodine therapy of benign thyroid
disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners …

Purpose TM-601 binds to malignant brain tumor cells with high affinity and does not seem to
bind to normal brain tissue. Preclinical studies suggest that iodine-131 (131I)–TM-601 may …

The proper treatment of hyperthyroidism depends on recognition of the signs and symptoms
of the disease and determination of the etiology. The most common cause of …

BACKGROUND. Concerns remain about risk of cancer after radioactive iodine (RAI)
treatment for hyperthyroidism, especially in organs that concentrate iodine. The objective …

Context: Patients treated with radioiodine (RAI) for hyperthyroidism have been reported to
be at increased risk for death. It is not clear whether the increased mortality is due to …

Epidemiologic studies have documented substantial increases in the frequency of nodular
thyroid disease. This trend is largely due to the increasing detection of nodules by the …

Background The management guidelines of the American Thyroid Association and
American Association of Clinical Endocrinologists for Graves' disease (GD) include any of …